Market Overview

Kroger's Q4 Comps Looking Flat, But That's A Good Thing


Kroger Co (NYSE: KR) surprised the Street in early December, when it reported in-line third quarter earnings but lowered the upper-end of its adjusted earnings per share guidance for the full year lower.

Kroger's stock has lost 9 percent over the past year and failed to participate in the "Trump rally" but analysts at Citi are finding some encouraging signs.

Alvin Concepcion, Citi's lead analyst covering the food and drug retail chain stocks, commented in a brief note that the first two months of Kroger's fourth quarter operations appear to show "solid" sales amid a favorable environment.

The analyst, citing data from Nielsen, believes that identical sales for the quarter thus far are running at 0.0 percent and this is actually positive since it would imply a running rate above investor expectations which was calling for negative identical sales.

Concepcion added that comparisons got sequentially easier by 120 basis points after the first two months of the quarter and if trends continue to accelerate then the company could be within range of achieving its guidance of reporting a "slightly positive" comps for the fourth quarter.

Finally, the analyst's findings relating to the competitive and promotional environment implies a stable and possibly better environment compared to the third quarter while fuel gross margins are also trending better than expected.

Latest Ratings for KR

Aug 2019UpgradesHoldBuy
May 2019MaintainsBuy
May 2019UpgradesMarket PerformOutperform

View More Analyst Ratings for KR
View the Latest Analyst Ratings

Posted-In: Freds Pharmacy Chain retailers Rite Aid Walgreens Walgreens Rite Aid MergerAnalyst Color Analyst Ratings


Related Articles (KR)

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Syndax's CEO Presents 3 Immediate Objectives, Possible Partnerships, Drug Pricing And More

Live Cattle Futures Losses Accelerate